Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
GYRE
Stock Latest News
Company Announcements
Gyre Therapeutics Reports Q1 2025 Financial Results
10d ago
GYRE
Premium
Pre-Earnings
GYRE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
14d ago
GYRE
Premium
Company Announcements
Gyre Therapeutics Highlights Fibrosis Treatment Strategy
22d ago
8K
GYRE
Premium
The Fly
new option listings on April 9th
1M ago
LIF
MBX
Premium
The Fly
Gyre Therapeutics announces NMPA approval for trial on pirfenidone
2M ago
GYRE
Premium
The Fly
Gyre Therapeutics announces publication of protocol for Phase 3 trial on F351
2M ago
GYRE
Premium
Company Announcements
Gyre Therapeutics Reports Strong Turnaround in 2024 Earnings
2M ago
GYRE
Premium
Company Announcements
Impact of New U.S. Regulations on Gyre Therapeutics: Potential Delisting Risks and Investor Concerns
2M ago
GYRE
Premium
The Fly
Catalyst Biosciences Inc trading resumes
2M ago
GYRE
Premium
The Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
2M ago
GYRE
Premium
The Fly
Gyre Therapeutics reports Q4 EPS 0c vs. ($1.39) last year
2M ago
GYRE
Premium
The Fly
Gyre Therapeutics initiated with an Outperform at Noble Capital
2M ago
GYRE
Premium
Company Announcements
Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects
3M ago
8K
GYRE
Premium
The Fly
Five new option listings and option delistings on January 21st
4M ago
SQ
ADN
Premium
Company Announcements
Leadership Changes at Gyre Therapeutics Amid Strategic Shift
4M ago
8K
GYRE
Premium
The Fly
Gyre Therapeutics appoints Ping Zhang to board of directors
4M ago
GYRE
Premium
Company Announcements
Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates
6M ago
GYRE
Premium
The Fly
Gyre Therapeutics files $150M mixed securities shelf
6M ago
GYRE
Premium
The Fly
Gyre: Last patient completes trial evaluating F351 for CHB-liver fibrosis
7M ago
GYRE
Premium
Company Announcements
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
9M ago
8K
GYRE
Premium
The Fly
Catalyst Biosciences Inc trading resumes
10M ago
GYRE
Premium
The Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
10M ago
GYRE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
